← Eichor
Study identifier: NCT06866444 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Duloxetine Metabolism and Fibromyalgia

Condition: Fibromyalgia · Duloxetine  ·  Sponsor: University of Utah

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

People with fibromyalgia report generalized body pain ("pain all over"), increased sensitivity to painful stimulation, chronic tiredness or low energy, sleep problems, and other physical and functional problems. The exact cause of the disorder is poorly understood, and treatment can be difficult. The degree to which duloxetine is helpful for people with fibromyalgia varies greatly. For some people, it is very helpful for managing fibromyalgia symptoms. For others, people may not notice any benefit. Yet for some, it is a little helpful and the effect is noticeable only when people forget to take the medicine. The purpose of this study is to collect data to better understand the relationship among gene types that control those enzymes, blood concentrations of duloxetine, and how it helps the symptoms.

This description comes directly from the study's public registry record.

Talk to the study team

Jake Steenblick, DNP  ·  801-585-1216  ·  jacob.steenblik@nurs.utah.edu

Natalie R Bennion, MPH  ·  801-585-7697  ·  Natalie.Bennion@utah.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Pain Management Center and Pain Research Center at the University of UtahSalt Lake City, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06866444